29/07/2026
A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906)
🌷https://doi.org/10.4143/crt.2025.426
Cancer Res Treat. 2026;58(3). Kwai Han Yoo